You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NT-I7 (Efineptakin alfa)

Showing 1 - 25 of 3,385
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

Not yet recruiting
  • Idiopathic CD4 Lymphopenia
  • Recombinant human interleukin (IL) 7-hyFc
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Refractory Diffuse Large B-cell Lymphoma, Refractory DLBCL, Not Otherwise Specified, Recurrent DLBCL Trial in Duarte, Saint

Recruiting
  • Refractory Diffuse Large B-cell Lymphoma
  • +4 more
  • Duarte, California
  • +2 more
Aug 9, 2022

High Grade Astrocytic Tumor, Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma Trial in Rochester (Biospecimen

Not yet recruiting
  • High Grade Astrocytic Tumor
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 18, 2022

Covid19 Trial in Seoul (GX-I7, GX-I7 vehicle)

Terminated
  • Covid19
  • Seoul, Korea, Republic of
    Borame Medical Center
Nov 25, 2022

AIDS-Related Kaposi Sarcoma, HIV Infection, Kaposi Sarcoma Trial in San Francisco, Bethesda, Seattle (Efineptakin alfa)

Recruiting
  • AIDS-Related Kaposi Sarcoma
  • +2 more
  • Efineptakin alfa
  • San Francisco, California
  • +2 more
Aug 9, 2022

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC) Trial in Poland, Spain, United States (NT-I7,

Active, not recruiting
  • Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
  • Louisville, Kentucky
  • +5 more
Dec 7, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Efineptakin alfa
  • San Francisco, California
    University of California San Francisco
Jul 7, 2022

Melanoma, Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in United States (NT-I7, atezolizumab)

Recruiting
  • Melanoma
  • +2 more
  • Duarte, California
  • +7 more
Oct 21, 2021

NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Mobile, Alabama
  • +14 more
May 12, 2022

Covid19 Trial in Jakarta Pusat (GX-I7)

Recruiting
  • Covid19
  • Jakarta Pusat, Indonesia
  • +1 more
Mar 22, 2021

Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant

Recruiting
  • Breast Carcinoma
  • +2 more
  • Recombinant human IL-7-hyFc (NT-I7)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Recurrent Glioblastoma Trial in Seoul (GX-I7, Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Seoul, Korea, Republic of
    Seoul St.Mary's Hospital of the Catholic University of Korea
Jan 3, 2022

Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

Recruiting
  • Progressive Multifocal Leukoencephalopathy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 2, 2022

COVID-19, SARS-CoV-2 Trial (NT-I7, Placebo, Blood for research purposes)

Withdrawn
  • COVID-19
  • SARS-CoV-2
  • (no location specified)
Jul 29, 2021

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury Trial in Worldwide (NT 201,

Recruiting
  • Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
  • NT 201
  • Placebo
  • Stamford, Connecticut
  • +53 more
Aug 19, 2022

Acute Intracranial Hemorrhage Trial in Worldwide (andexanet alfa, Usual Care)

Recruiting
  • Acute Intracranial Hemorrhage
  • andexanet alfa
  • Usual Care
  • Birmingham, Alabama
  • +239 more
Jan 30, 2023

Schizophrenia Trial in Worldwide (SEP-363856)

Completed
Has Results
  • Schizophrenia
  • Little Rock, Arkansas
  • +29 more
Feb 8, 2022

Heart Failure With Reduced Ejection Fraction Trial in Alexandria (Empagliflozin 10 MG)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Empagliflozin 10 MG
  • Alexandria, Egypt
    Alexandria University
Mar 9, 2023

Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma, Metastatic Non-Cutaneous Melanoma Trial in Canada, Ireland, United

Active, not recruiting
  • Metastatic Cutaneous Melanoma
  • +15 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +582 more
Jan 28, 2023

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Rozibafusp Alfa, Placebo for Rozibafusp Alfa)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • Rozibafusp Alfa
  • Placebo for Rozibafusp Alfa
  • Birmingham, Alabama
  • +146 more
Feb 1, 2023

Glycogen Storage Disease Type II-Pompe's Disease Trial in Worldwide (Avalglucosidase alfa (GZ402666), Alglucosidase alfa

Active, not recruiting
Has Results
  • Glycogen Storage Disease Type II-Pompe's Disease
  • Avalglucosidase alfa (GZ402666)
  • Alglucosidase alfa (GZ419829)
  • Valhalla, New York
  • +9 more
May 3, 2022

Active Systemic Lupus Erythematosus Trial in Worldwide (Efavaleukin Alfa, Placebo, Standard of Care)

Recruiting
  • Active Systemic Lupus Erythematosus
  • Efavaleukin Alfa
  • +2 more
  • Birmingham, Alabama
  • +148 more
Jan 18, 2023

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023